207 related articles for article (PubMed ID: 26151312)
41. Towards building a disease-phenotype knowledge base: extracting disease-manifestation relationship from literature.
Xu R; Li L; Wang Q
Bioinformatics; 2013 Sep; 29(17):2186-94. PubMed ID: 23828786
[TBL] [Abstract][Full Text] [Related]
42. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
43. Drug discovery in a multidimensional world: systems, patterns, and networks.
Dudley JT; Schadt E; Sirota M; Butte AJ; Ashley E
J Cardiovasc Transl Res; 2010 Oct; 3(5):438-47. PubMed ID: 20677029
[TBL] [Abstract][Full Text] [Related]
44. Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis.
Guo LK; Su Y; Zhang YY; Yu H; Lu Z; Li WQ; Yang YF; Xiao X; Yan H; Lu TL; Li J; Liao YD; Kang ZW; Wang LF; Li Y; Li M; Liu B; Huang HL; Lv LX; Yao Y; Tan YL; Breen G; Everall I; Wang HX; Huang Z; Zhang D; Yue WH
Mil Med Res; 2023 Jun; 10(1):24. PubMed ID: 37269009
[TBL] [Abstract][Full Text] [Related]
45. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
Jarada TN; Rokne JG; Alhajj R
BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
[TBL] [Abstract][Full Text] [Related]
46. PREDICT: a method for inferring novel drug indications with application to personalized medicine.
Gottlieb A; Stein GY; Ruppin E; Sharan R
Mol Syst Biol; 2011 Jun; 7():496. PubMed ID: 21654673
[TBL] [Abstract][Full Text] [Related]
47. Discovery and preclinical validation of drug indications using compendia of public gene expression data.
Sirota M; Dudley JT; Kim J; Chiang AP; Morgan AA; Sweet-Cordero A; Sage J; Butte AJ
Sci Transl Med; 2011 Aug; 3(96):96ra77. PubMed ID: 21849665
[TBL] [Abstract][Full Text] [Related]
48. Network-based inference methods for drug repositioning.
Chen H; Zhang H; Zhang Z; Cao Y; Tang W
Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
[TBL] [Abstract][Full Text] [Related]
49. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
[TBL] [Abstract][Full Text] [Related]
50. Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing.
Xu R; Wang Q
BMC Bioinformatics; 2013 Jun; 14():181. PubMed ID: 23742147
[TBL] [Abstract][Full Text] [Related]
51. Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning.
Alaimo S; Giugno R; Pulvirenti A
Methods Mol Biol; 2016; 1415():441-62. PubMed ID: 27115647
[TBL] [Abstract][Full Text] [Related]
52. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
53. Realizing drug repositioning by adapting a recommendation system to handle the process.
Ozsoy MG; Özyer T; Polat F; Alhajj R
BMC Bioinformatics; 2018 Apr; 19(1):136. PubMed ID: 29649971
[TBL] [Abstract][Full Text] [Related]
54. Drug Repositioning and Target Finding Based on Clinical Evidence.
Kaneko S; Nagashima T
Biol Pharm Bull; 2020; 43(3):362-365. PubMed ID: 32115497
[TBL] [Abstract][Full Text] [Related]
55. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
56. Exploration and analysis of drug modes of action through feature integration.
Xin M; Fan J; Liu M; Jiang Z
Mol Biosyst; 2017 Jan; 13(2):425-431. PubMed ID: 28092388
[TBL] [Abstract][Full Text] [Related]
57. Computational drug repurposing to predict approved and novel drug-disease associations.
Khalid Z; Sezerman OU
J Mol Graph Model; 2018 Oct; 85():91-96. PubMed ID: 30130693
[TBL] [Abstract][Full Text] [Related]
58. Combining phenome-driven drug-target interaction prediction with patients' electronic health records-based clinical corroboration toward drug discovery.
Zhou M; Zheng C; Xu R
Bioinformatics; 2020 Jul; 36(Suppl_1):i436-i444. PubMed ID: 32657406
[TBL] [Abstract][Full Text] [Related]
59. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
Brylinski M; Naderi M; Govindaraj RG; Lemoine J
J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
[TBL] [Abstract][Full Text] [Related]
60. Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease.
Chen Y; Cai X; Xu R
AMIA Annu Symp Proc; 2015; 2015():1851-60. PubMed ID: 26958284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
